We reiterate our BUY rating on PNJ with 26% total return while increasing our TP by 4% mainly on a higher target peer-based PER and higher TTM EPS. Q1 2017 results reinforce our optimism on PNJ as revenue and estimated recurring NPAT jumped 34% and 30%, r